questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Lyases
Carbon-sulfur lyases
Lactoyl glutathione lyase
Lactoyl glutathione lyase : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lactoyl glutathione lyase : Questions médicales les plus fréquentes",
"headline": "Lactoyl glutathione lyase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lactoyl glutathione lyase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-19",
"dateModified": "2025-02-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lactoyl glutathione lyase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Carbon-sulfur lyases",
"url": "https://questionsmedicales.fr/mesh/D013437",
"about": {
"@type": "MedicalCondition",
"name": "Carbon-sulfur lyases",
"code": {
"@type": "MedicalCode",
"code": "D013437",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.520.300"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lactoyl glutathione lyase",
"alternateName": "Lactoylglutathione Lyase",
"code": {
"@type": "MedicalCode",
"code": "D007791",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yu-Zhong Zhang",
"url": "https://questionsmedicales.fr/author/Yu-Zhong%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "College of Marine Life Sciences, Frontiers Science Center for Deep Ocean Multispheres and Earth System, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Julie D Saba",
"url": "https://questionsmedicales.fr/author/Julie%20D%20Saba",
"affiliation": {
"@type": "Organization",
"name": "Children's Hospital Oakland Research Institute, University of California, San Francisco Benioff Children's Hospital Oakland, Oakland, CA 94609 jsaba@chori.org."
}
},
{
"@type": "Person",
"name": "Lidia de Bari",
"url": "https://questionsmedicales.fr/author/Lidia%20de%20Bari",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies-CNR, Via G. Amendola 122/O, 70126 Bari, Italy."
}
},
{
"@type": "Person",
"name": "Marissa N Trujillo",
"url": "https://questionsmedicales.fr/author/Marissa%20N%20Trujillo",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Erin Q Jennings",
"url": "https://questionsmedicales.fr/author/Erin%20Q%20Jennings",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Compounded medications for cardiovascular use in neonatology: an integrative review.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36102396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1984-0462/2023/41/2021167"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of Apparatus and Adapter on In vitro Drug Release of Ophthalmic Semisolid Drug Products.",
"datePublished": "2023-09-07",
"url": "https://questionsmedicales.fr/article/37679656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11095-023-03586-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Economic Considerations and Cost-Saving Strategies for Nonsterile Compounding Education.",
"datePublished": "2023-07-16",
"url": "https://questionsmedicales.fr/article/37454811",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajpe.2023.100571"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advancing algorithmic drug product development: Recommendations for machine learning approaches in drug formulation.",
"datePublished": "2023-08-09",
"url": "https://questionsmedicales.fr/article/37562550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejps.2023.106562"
}
},
{
"@type": "ScholarlyArticle",
"name": "Accelerated Predictive Stability Study of a Pediatric Drug Product for a Supplemental New Drug Application.",
"datePublished": "2024-06-06",
"url": "https://questionsmedicales.fr/article/38844721",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1208/s12249-024-02848-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lyases",
"item": "https://questionsmedicales.fr/mesh/D008190"
},
{
"@type": "ListItem",
"position": 5,
"name": "Carbon-sulfur lyases",
"item": "https://questionsmedicales.fr/mesh/D013437"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lactoyl glutathione lyase",
"item": "https://questionsmedicales.fr/mesh/D007791"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lactoyl glutathione lyase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lactoyl glutathione lyase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lactoyl glutathione lyase",
"description": "Comment diagnostiquer une déficience en lactoyl glutathione lyase ?\nQuels tests sont utilisés pour évaluer l'activité de cette enzyme ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nY a-t-il des biomarqueurs associés à cette enzyme ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés à cette enzyme ?",
"url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Drug+Compounding&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lactoyl glutathione lyase",
"description": "Quels sont les symptômes d'une déficience en lactoyl glutathione lyase ?\nLa déficience peut-elle causer des problèmes cutanés ?\nY a-t-il des symptômes digestifs associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on observer des symptômes psychologiques ?",
"url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Drug+Compounding&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lactoyl glutathione lyase",
"description": "Comment prévenir les complications liées à cette enzyme ?\nY a-t-il des tests de dépistage recommandés ?\nLes antioxydants peuvent-ils prévenir des problèmes ?\nEst-il important de gérer le stress ?\nLes vaccinations sont-elles importantes ?",
"url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Drug+Compounding&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lactoyl glutathione lyase",
"description": "Quels traitements sont disponibles pour la déficience en lactoyl glutathione lyase ?\nLa thérapie génique est-elle une option ?\nDes changements alimentaires peuvent-ils aider ?\nY a-t-il des médicaments spécifiques à éviter ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Drug+Compounding&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lactoyl glutathione lyase",
"description": "Quelles complications peuvent survenir avec cette déficience ?\nLa déficience peut-elle affecter le système immunitaire ?\nY a-t-il des risques de maladies chroniques ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?",
"url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Drug+Compounding&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lactoyl glutathione lyase",
"description": "Quels sont les facteurs de risque pour cette déficience ?\nL'âge joue-t-il un rôle dans le risque ?\nY a-t-il des maladies associées à ce risque ?\nLe mode de vie influence-t-il le risque ?\nLes facteurs environnementaux sont-ils significatifs ?",
"url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Drug+Compounding&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en lactoyl glutathione lyase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent confirmer la déficience."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité de cette enzyme ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques mesurant l'activité enzymatique dans des échantillons biologiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes de stress oxydatif, comme la fatigue ou des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés à cette enzyme ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux de glutathion et de lactate peuvent être des biomarqueurs."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés à cette enzyme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en lactoyl glutathione lyase ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, troubles neurologiques, et susceptibilité accrue aux infections."
}
},
{
"@type": "Question",
"name": "La déficience peut-elle causer des problèmes cutanés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées et une sensibilité accrue peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes digestifs associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles digestifs comme des nausées peuvent être présents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes psychologiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de l'humeur et de l'anxiété peuvent être liés à cette déficience."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées à cette enzyme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain et une alimentation équilibrée peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests de dépistage recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage génétique peuvent être recommandés pour les familles à risque."
}
},
{
"@type": "Question",
"name": "Les antioxydants peuvent-ils prévenir des problèmes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une consommation adéquate d'antioxydants peut réduire le stress oxydatif."
}
},
{
"@type": "Question",
"name": "Est-il important de gérer le stress ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress est cruciale pour maintenir une bonne santé cellulaire."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir les infections chez les personnes à risque."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la déficience en lactoyl glutathione lyase ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments de glutathion et des antioxydants peuvent être recommandés."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore largement disponible."
}
},
{
"@type": "Question",
"name": "Des changements alimentaires peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut soutenir la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques à éviter ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments oxydants doivent être évités pour réduire le stress oxydatif."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés selon la gravité des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec cette déficience ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections récurrentes et des troubles neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "La déficience peut-elle affecter le système immunitaire ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut affaiblir le système immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies chroniques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un stress oxydatif accru peut contribuer à des maladies chroniques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications potentielles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour cette déficience ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux et des expositions environnementales peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants sont plus susceptibles de présenter des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des maladies associées à ce risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies métaboliques peuvent être liées à un risque accru de déficience."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain peut augmenter le risque de complications liées à cette enzyme."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux sont-ils significatifs ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut augmenter le risque de déficience."
}
}
]
}
]
}
To analyze the profile of the compounded cardiovascular medicines prescribed in neonatology in Brazil....
An integrative bibliographic review was carried out, including studies published in the last 20 years. The used descriptors were: Intensive Care Neonatal, Off-Label Use, Pharmaceutical Preparations, i...
The profile of routine prescrption in the neonatal unit was evaluated. The main cardiovascular medications prescribed as compounding formulation were: Spironolactone, Captopril, Furosemide, Hydrochlor...
It was possible to analyze the profile of compounded cardiovascular medicines prescribed in neonatology in Brazil. The results showed the need for the development of medications suitable for the neona...
In vitro release testing (IVRT) is a widely used tool for evaluating the quality and performance of drug products. However, standardized sample adaptors or drug release apparatus setups for IVRT studi...
Dexamethasone (DEX), a steroidal ingredient commonly used in ophthalmic drug products, was selected as a model drug. Ointments were prepared by mixing DEX in white petrolatum using a high shear mixer....
The sample adaptor setups had a minimal impact on cumulative drug release amount per area or release rate while USP IV apparatus with agitated flow enhanced drug release rates. The USP apparatus I wit...
USP apparatuses and sample adaptors are critical considerations for IVRT. Two-sided semisolid adapter provides higher cumulative release, facilitating the discrimination between low drug content ophth...
To determine the economic considerations, including cost-saving strategies, associated with nonsterile compounding education for students in schools and colleges of pharmacy across the United States....
An electronic survey was sent to the American Association of Colleges of Pharmacy Pharmaceutics Section and Laboratory Instructor's Special Interest Group members. Quantitative and qualitative data we...
Of 555 surveys sent, 46 were completed. Reported annual compounding budgets ranged from $3000 to $96,000. Reported annual equipment maintenance costs ranged from $400 to $18,000. Fifty percent of resp...
Findings from this study may assist pharmacy administrators and course directors in evaluating the costs associated with nonsterile compounding education across the Academy and, more importantly, dete...
Artificial intelligence is a rapidly expanding area of research, with the disruptive potential to transform traditional approaches in the pharmaceutical industry, from drug discovery and development t...
In this paper, we report two Accelerated Stability Assessment Program (ASAP) studies for a pediatric drug product. Whereas the first study using a generic design failed to establish a predictive model...
Magistral compounding has always been an integral part of pharmacy practice. The increasing demand worldwide for personalized drug treatments might be accommodated by an increase in magistral compound...
To investigate how 3D printing can be integrated into the existing compounding system by taking regulatory, economic, and profession-oriented aspects into account....
Semi-structured interviews were conducted with relevant Dutch stakeholders representing various health institutions, such as health ministries and boards, professional bodies, and different types of p...
A total of 15 Dutch stakeholders were interviewed. It was found that the prevalence of compounding in community pharmacies in the Netherlands has decreased as a result of the practice shifting to spec...
In the Netherlands, specialized compounding pharmacies have largely taken over compounding activities. 3D printing could be introduced within this system; however, challenges regarding how to regulate...
The development of liposome-based drugs was severely limited due to inefficient loading strategies. Herein, we developed a click reaction-mediated loading procedure by designing an enzyme-sensitive ma...
Treatment of metastatic lymph nodes (LNs) is challenging due to their unique architecture and biophysical traits. Systemic chemotherapy fails to impede tumor progression in LNs due to poor drug uptake...
Automated compounding device (ACD) are increasingly used for parenteral nutrition (PN) bag production, and their acquisition must be sufficiently thought. The law requires the qualification of these A...
The objective of this study was to prepare poly(lactide-co-glycolide) (PLGA) microparticles loaded with nanosized drug by combining non-aqueous wet bead milling and microencapsulation. 200-300 nm dexa...